195 related articles for article (PubMed ID: 37766222)
1. Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer.
Nicola Candia AJ; Garcia Fallit M; Peña Agudelo JA; Pérez Küper M; Gonzalez N; Moreno Ayala MA; De Simone E; Giampaoli C; Casares N; Seilicovich A; Lasarte JJ; Zanetti FA; Candolfi M
Viruses; 2023 Aug; 15(9):. PubMed ID: 37766222
[TBL] [Abstract][Full Text] [Related]
2. Targeting Inhibition of Foxp3 by MMP2/9 Sensitive Short Peptide Linked P60 Fusion Protein 6(P60-MMPs) to Enhance Antitumor Immunity.
Ding X; Peng C; Li Y; Liu J; Song Y; Cai B; Xiang M; Zhang J; Wang Z; Wang L
Macromol Biosci; 2020 Jul; 20(7):e2000098. PubMed ID: 32449306
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic blockade of Foxp3 in experimental breast cancer models.
Moreno Ayala MA; Gottardo MF; Imsen M; Asad AS; Bal de Kier Joffé E; Casares N; Lasarte JJ; Seilicovich A; Candolfi M
Breast Cancer Res Treat; 2017 Nov; 166(2):393-405. PubMed ID: 28756536
[TBL] [Abstract][Full Text] [Related]
4. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
[TBL] [Abstract][Full Text] [Related]
5. The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer.
Zhang L; Wang XI; Ding J; Sun Q; Zhang S
Ann Diagn Pathol; 2019 Jun; 40():143-151. PubMed ID: 31096176
[TBL] [Abstract][Full Text] [Related]
6. A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice.
Casares N; Rudilla F; Arribillaga L; Llopiz D; Riezu-Boj JI; Lozano T; López-Sagaseta J; Guembe L; Sarobe P; Prieto J; Borrás-Cuesta F; Lasarte JJ
J Immunol; 2010 Nov; 185(9):5150-9. PubMed ID: 20870946
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.
Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO
Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of FOXP3 expression in triple-negative breast cancer.
Lee S; Cho EY; Park YH; Ahn JS; Im YH
Acta Oncol; 2013 Jan; 52(1):73-81. PubMed ID: 23075422
[TBL] [Abstract][Full Text] [Related]
10. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
J Immunother Cancer; ; . PubMed ID: 36126994
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
